InvestorsHub Logo
Followers 283
Posts 1162
Boards Moderated 0
Alias Born 10/04/2020

Re: twaflyer1 post# 61469

Wednesday, 05/05/2021 11:15:50 AM

Wednesday, May 05, 2021 11:15:50 AM

Post# of 118366
Well Said!

You set the record straight wonderfully in regard to Bio-Pharma start ups. ANY pharmaceutical can takes years or even decades to devlope.

RGBP has made remarkable headway over the years to get where they are today, even attracting the attention AND collaboration with Eli Lilly!

Now THAT RIGHT THERE PROVES what they have and where they're going for reason NO BIG PHARMA would look at any company twice that had nothing to offer of any value.

FACT NOT FICTION...and I know because I'm a Clinical Trials Doc that has conducted dozens of Big Pharma drug trials over the past 30+ years, and I can tell everyone here in no uncertain terms to "hang on to your shares" because at some point this company is either going to be bought out straight up OR they will bring their bio-pharma patents to Market via a CRO, which now-a-days is the preferred way to go which is what Oncology Pharma does with ALL its Patents.

I'm just stating the facts the way they are, and yes I hold several Million shares of this company, and I would NOT of done that unless I was certain of what they have just Eli Lilly was (is).

For those of you who aren't aware of this, Google Eli Lilly Regen Biopharma and see what comes back!

Oh, and HERE'S ONE MORE THING, JUST OUT YESTERDAY!!! (5/4/21)

https://ksusentinel.com/2021/05/04/hematopoietic-stem-cell-transplantation-market-to-see-a-massive-growth-during-the-forecast-period-key-players-pluristem-therapeutics-inc-cellgenix-gmbh-regen-biopharma-inc/

ANY QUESTIONS???


Be well and prosper...